Clinical Trial Update: Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety, tolerability, and efficacy of IONIS-GHR-LRx in acromegaly patients on long-acting somatostatin receptor ligands; study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• IONIS-GHR-LRx

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Acromegaly | Phase 2 | Status: COMPLETED | Results posted: 2022-11-14